Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China11 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults | brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder | Not yet recruiting | Phase 3 | 2026-09-25 | NCT07835152 | |
| Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A) | Alzheimer s Disease | Recruiting | Phase 3 | 2026-09-22 | NCT07262645 | |
| Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, nephritis, systemic lupus erythematosus, urinary system disorder | Recruiting | Phase 4 | 2026-07-22 | NCT07719140 | |
| Vaginal Function Exercisers and Vaginal Dilation Irrigation Drug Administration Tubes Are Used for Vaginal Rehabilitation Therapy in Pelvic Radiotherapy | Indicated for Pelvic Radiotherapy, Vaginal Rehabilitation, and Alleviation of Late Toxic Reactions in the Vagina | Enrolling by invitation | Not applicable | 2026-03-16 | NCT07473271 | |
| Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge | Immune-Related Adverse Events | Recruiting | Not stated | 2026-03-06 | NCT07453342 | |
| An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not applicable | 2026-03-05 | NCT07452003 | |
| HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors | Locally Advanced or Metastatic Pancreatic Cancer With | Recruiting | Phase 1 / Phase 2 | 2026-01-14 | NCT07296341 | |
| Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria | Hemic and Lymphatic Diseases, Hemoglobinuria, Paroxysmal, anemia, bone marrow disorder, hematologic disorder, hemolytic anemia, myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuria | Active, not recruiting | Phase 2 | 2025-12-24 | NCT06238544 | |
| Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer | First-line Treatment of Metastatic Pancreatic Cancer | Recruiting | Phase 3 | 2025-12-09 | NCT07238283 | |
| SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer | Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Recruiting | Phase 1 / Phase 2 | 2025-06-06 | NCT06859775 | |
| A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Phase 2 | 2025-05-08 | NCT06962267 |